Insiders who reported open-market trades in the last 12 months at the companies Nadav Kidron files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Joshua Hexter - $747K in ORMP purchases and sales in the last 12 months
Avraham Gabay - $421K in ORMP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Nadav Kidron is a corporate insider, tracked as President and CEO, Director of ORAMED PHARMACEUTICALS INC. (ORMP). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Nadav Kidron submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Nadav Kidron is President and CEO, Director of ORAMED PHARMACEUTICALS INC. (ORMP). 9 SEC Form 4 filings on record going back to 2024, most recently on 25 September 2026.
Recent transactions
11
The latest 11 SEC Form 4 transactions reported by Nadav Kidron.
InsiderAlpha's records for Nadav Kidron go back to 2024: 9 primary Form 4 filings, an average of 3.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
